Wheatley Laboratory
-
Head of Laboratory
Dr Adam Wheatley+61 449 221 480
Research Overview
View Dr Wheatley's latest PubMed publications listing here, and ORCID publications here.
View Dr Wheatley's Laboratory page here.
Viral infections comprise both an ongoing and emerging threat to the health, wealth and security of the global community, best evidenced by the recent turmoil inflicted by the novel coronavirus SARS-CoV-2. The resilience of human populations can be significantly enhanced by high quality vaccines and drugs.
The Wheatley lab seeks to increase our understanding of immunity to SARS-CoV-2, Influenza and other pandemic viruses, in order to facilitate rational improvement of vaccination strategies and treatment paradigms. With a primary focus on humoral aspects of immunity, we aim:
- To explore immunological mechanisms that underpin successful vaccination, including the factors that maximise the protective efficacy, breadth and durability of anti-viral immunity.
- To design, develop and clinically assess the next-generation of vaccine platforms and regimens, including self-assembling nanoparticle and mRNA-based technologies.
- To discover, optimise and clinically develop human/humanised monoclonal antibodies as potent antiviral drugs for treatment or prevention of viral infectious diseases.
Staff
Mai Vu, Post-Doctoral Fellow
Rosela Webster, Post-Doctoral Fellow
Robyn Esterbauer, Research Assistant
Andrew Kelly, Research Assistant
Devaki Pilapitiya, PhD Student
Yee-Chen Liu, PhD Student
Research Opportunities
This research project is available to PhD students, Masters by Research, Honours students, Post Doctor Researchers to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.